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Abstract 
This paper will discuss the U.S. American secondary market for life insurances, 
also known as the market for life settlements. The structure of this paper will be 
as follows. 
First, a very basic introduction to life settlements will be provided, explaining the 
fundamental structure of a life settlement process, the players involved, the life 
insurance types settled, and the terminology used. A short history lesson on the 
development of life settlements serves as a round-up. 
The second part will build on these basics to describe the transaction processes 
and involved parties for actually setting up a life settlement. A number of 
diagrams will help to develop an overview over the basic flows of the value 
chain. 
The third part will analyze life settlements as a financial asset. While the first 
two chapters are rather theoretical, this part will appear more mathematically. 
The valuation of a life insurance as well as the valuation of a life settlement will 
be explained in detail, followed by an insight on the pricing of life settlements. A 
view on the life settlements’ uncorrelated nature to the capital markets and 
possible investment strategies close this chapter. 
The fourth chapter will take a closer look at the plethora of risks involved for the 
buying-side in life settlement transactions, which mainly consists of brokers, 
providers, and investors. Whenever possible, solution proposals for these 
problems are given. 
The fifth chapter will finally take a look at the development of the life settlements 
market and, by doing so, will find a few answers to the sudden halt of a market 
which once had shown exponential growth. Afterwards, the ethical issues 
surrounding life settlements will be discussed. 
 
The mandatory German abstract can be found at the end of this paper, in Appendix A. 
  
3 Life Settlements – The Secondary Market for Life Insurances 
 
 
Magisterarbeit  Alexander Becker, Bakk. 
Table of Contents 
 
1 Introduction: The Principles of Life Settlements .......................................... 6 
1.1 Overview ............................................................................................... 6 
1.2 Definition of the Term “Life Settlement” ................................................. 6 
1.3 Types of Life Insurance Contracts for Life Settlement Transactions ..... 8 
1.3.1 Overview ......................................................................................... 8 
1.3.2 Universal Life .................................................................................. 8 
1.3.3 Variable Universal Life .................................................................... 8 
1.3.4 Term Life Insurance ........................................................................ 9 
1.3.5 Whole Life Insurance ...................................................................... 9 
1.4 The Historical Development of the Life Settlements Market .................. 9 
2 Transaction Processes and Involved Parties ............................................ 12 
2.1 Overview ............................................................................................. 12 
2.2 Life Settlement Transaction Participants ............................................. 12 
2.2.1 Direct Participants ......................................................................... 12 
2.2.2 Indirect Participants ...................................................................... 13 
2.3 Life Settlement Transaction Processes ............................................... 14 
3 Life Settlements as an Asset Class ........................................................... 18 
3.1 Overview ............................................................................................. 18 
3.2 The Valuation of the Underlying Life Insurance Policy ........................ 18 
3.3 The Difference between Normal and Impaired Lives........................... 19 
3.4 The Valuation of a Life Settlement ...................................................... 21 
3.5 The Pricing of a Life Settlement .......................................................... 22 
3.5.1 The Theory behind Life Settlement Pricing ................................... 22 
3.5.2 The Importance of Medical Underwriting ...................................... 24 
3.5.3 Deterministic Pricing ..................................................................... 25 
3.5.4 Probabilistic Pricing ...................................................................... 25 
Life Settlements – The Secondary Market for Life Insurances 4 
 
 
Magisterarbeit  Alexander Becker, Bakk. 
3.6 No Correlation to Financial Markets as Additional Non-Monetary Value
 27 
3.7 Taxation Issues ................................................................................... 29 
3.8 Investment Strategies .......................................................................... 29 
3.8.1 “Buy and Hold” Strategy ............................................................... 30 
3.8.2 “Leverage” Strategy ...................................................................... 30 
3.8.3 “Buy, Package, and Resell” Strategy ............................................ 30 
4 The Risks for Life Settlement Buyers ........................................................ 32 
4.1 Overview ............................................................................................. 32 
4.2 Contestability Period ........................................................................... 33 
4.3 Missing Body Risk ............................................................................... 33 
4.4 Insurable Interest Risk ......................................................................... 34 
4.5 Incorrect Purchase Price ..................................................................... 35 
4.5.1 Overview ....................................................................................... 35 
4.5.2 Stress Tests .................................................................................. 35 
4.5.3 Eligibility Criteria ........................................................................... 37 
4.5.4 Multiple Underwriters .................................................................... 37 
4.5.5 Pricing Criteria .............................................................................. 38 
4.5.6 Reinsurance.................................................................................. 38 
4.6 Life Insurance Company Credit Risk ................................................... 38 
4.7 Increase in Premiums due to Increase in the Cost of Insurance ......... 39 
4.8 Longevity Risk ..................................................................................... 39 
4.8.1 Overview ....................................................................................... 39 
4.8.2 Longevity-Extension Insurance / Mortality Wraps ......................... 40 
4.8.3 Vanilla Longevity/Survivor Swaps ................................................. 40 
5 The Life Settlements Market ..................................................................... 42 
5.1 Overview ............................................................................................. 42 
5.2 The Modern History of the Life Settlements Market ............................ 42 
5 Life Settlements – The Secondary Market for Life Insurances 
 
 
Magisterarbeit  Alexander Becker, Bakk. 
5.2.1 Milestones in Life Settlement History ............................................ 42 
5.2.2 The Life Settlement Market Volumes from 1989 to 2010 .............. 44 
5.3 Ethical Issues Surrounding Life Settlements ....................................... 45 
5.3.1 Arguments Pro Life Settlements ................................................... 45 
5.3.2 Arguments Contra Life Settlements .............................................. 47 
6 Conclusion ................................................................................................ 49 
Appendix .......................................................................................................... 51 
A Verpflichtende deutsche Zusammenfassung der Arbeit gemäß Vorschrift
 51 
References ....................................................................................................... 53 
 
List of Figures 
Figure 1. Self-provided diagram. Simplified Life Settlement Transaction Process .................. 7 
Figure 2. Self-provided adaption of (Chaplin et. al, 2009). Information flow in a typical 
life settlement transaction ......................................................................................... 14 
Figure 3. McNealy & Frith, 2006, p.31. Schematic of the Life Settlement Supply Chain ....... 15 
Figure 4. Self-provided adaption of Casey & Sherman (2007, p.56). Life Settlement 
Transaction “Players” ............................................................................................... 15 
Figure 5. (Perdon, Tomkins, Allsop, & Williams, 2011, p. 4). Life Settlements 
Transaction Process ................................................................................................ 17 
Figure 6. Self-provided diagram. Value of a Life Insurance Policy........................................ 19 
Figure 7. Self-provided diagram. Difference between Normal and Impaired Lives ............... 20 
Figure 8. Self-provided diagram. Cash Flows of a Life Settlement ....................................... 21 
Figure 9. Self-provided diagram. Cash Flows of a Bond ...................................................... 21 
Figure 10. Selv-provided illustration of the concept of asking and bidding prices ................. 23 
Figure 11. Self-provided illustration. The Leverage Strategy for Life Settlements ................. 30 
Figure 12. Self-provided adaption of (Perera & Reeves, 2006, p.56), General Summary 
of Risks for Life Settlement Brokers ......................................................................... 32 
Figure 13. Self-provided illustration of history milestones ..................................................... 42 
Figure 14. Self-provided illustration of market life settlement market volumes from 1989 
to 2010 dervied from various sources ....................................................................... 44 
  
Life Settlements – The Secondary Market for Life Insurances 6 
 
 
Magisterarbeit  Alexander Becker, Bakk. 
1 Introduction: The Principles of Life Settlements 
1.1 Overview 
The first chapter will give a basic overview on the very principles of life 
settlements. First, the terminology will be clarified, ranging from a definition of 
the life settlement term to a simplified explanation of the transaction process 
and the parties involved. Furthermore, the types of life insurance policies which 
could be the asset’s underlying will be described briefly, followed by a short 
history lesson on the development and evolution of the life settlements market. 
1.2 Definition of the Term “Life Settlement” 
Before any further discussion on life settlements can be started, a definition of 
the term has to be provided. Fortunately, most definitions are quite in unison. 
The following paragraphs show definitions which are very much to the point: 
“A life settlement is the purchase of a life insurance policy from the 
policyholder. In return for buying the policy the purchaser continues to 
pay the premiums on the policy, and collect the death benefit when the 
policy matures.” (Rosenfeld, 2009, p. 4) 
“[A life settlement is] the selling of one's life insurance policy to a third 
party for a one time cash payment. The purchaser then becomes the 
beneficiary of the policy and begins paying the premiums. Typically the 
purchaser is an experienced institutional investor, and policies will have 
face amounts in excess of $250,000.“ (Investopedia, 2011) 
“Life insurance settlements, or life settlements, are life insurance policies 
owned by investor beneficiaries on the lives of unrelated individuals. With 
life settlements, investors make substantial payments to the insured 
individuals upon purchasing such policies, pay any remaining premiums, 
and collect the death benefits upon the demise of the insured 
individuals.” (Nurnberg & Lackey, 2010, p. 513) 
So, judging from these quotes, the market for life settlements is a secondary 
market for life insurances. As such, it enables holders of life insurance policies 
to sell these contracts to unrelated third-party investors. In other words: Life 
insurance contracts become a financial asset class. 
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Furthermore, it can be conclude
in a life settlement transaction:
1. The original life insurance policyholder
2. The life insurance company
3. The purchaser, usually some kind of investor
 
Figure 1 shows a simplified illustration of the 
Figure 1. Self-provided diagram. 
 
Initially, the policyholder pays regular premiums to an insurance company, 
which in return will pay a certain amount
death (“death benefit”). For the purpose of a life settlement transaction, a 
purchaser assumes the obligations and benefits of the policyholder, the latter 
receiving a one-time payment (“purchase price”) as a compensation.
result, the life insurance policy still stays active, but once the policyholder dies, 
the purchaser – who continues to pay the premiums to the insurance company 
– will receive the death benefit upon maturity. The policy still matures with the 
death of the original policyholder, not with that of the new beneficiary.
Prihoda, 2010, p. 4) 
In reality, the policyholder
from the person to receive the death benefit (
whose life and death the policy is based on (
Aspinwall, & Venn, 2009, p. 7)
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purpose of a life insurance is to secure the needs of dependants. Still, for the 
purpose of illustrating the life settlement transaction process in a simplified way, 
aggregating these three parties as one “policyholder” is sufficient and avoids 
further confusion. 
1.3 Types of Life Insurance Contracts for Life Settlement 
Transactions 
1.3.1 Overview 
According to (Chaplin, Aspinwall, & Venn, 2009, pp. 9-12), four types of life 
insurance contracts may be featured in a life settlement transaction: Universal 
life, variable universal, term insurance, and whole life policies. The following 
subchapters will briefly explain these policy types and their underlying concepts. 
1.3.2 Universal Life 
Originally designed in the 1980’s to be an alternative to investments in the 
financial markets, universal life insurance contracts combine a life insurance 
policy with a savings/cash account (Lewis, 2008). (Chaplin, Aspinwall, & Venn, 
2009, pp. 9-10) claim that “universal life policies account for over 95% of the life 
insurance policies transacted in the life settlements markets and represent the 
majority of in-force life insurance policies in the United States”. Therefore, most 
life settlements are based on universal life policies. 
For this type of insurance, the policyholder pays regular premiums to the 
insurance company, the premiums being accrued into a cash account. This 
savings account will generate interest over time, the interest rate (or crediting 
rate) being determined by the performance of the insurance company’s financial 
assets. From this account, the insurer will debit administrative fees and the cost 
of insurance (COI) to compensate the mortality risk at stake. In exchange, the 
insurer pays a fixed or variable death benefit (depending on the contract) once 
the insured dies; the variable death benefit usually is a fixed amount plus the 
current value of the savings account. (Baldwin, 2001, pp. 53-78) 
1.3.3 Variable Universal Life 
Variable Universal Life (VUL) is quite similar to Universal Life policies, and 
therefore it also accumulates cash plus interest in a savings account. The main 
difference, however, is the way in which the cash account’s money is being 
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invested. While for universal life policies these are mostly long-term, low-risk, 
fixed rate instruments, VUL promises higher returns but also higher risks due to 
investing the money into equities and other asset classes on the financial 
market. (Rybka, 1997, pp. 40-46) 
1.3.4 Term Life Insurance 
Term Life Insurance (or Term Insurance) policies have a fixed term and pay out 
a fixed amount of money to the beneficiary if the insured person dies within the 
agreed timeframe. No cash account is being maintained and once the term runs 
out, the policy ceases to exist. The policyholder simply pays premiums to the 
insurance company based on the insured’s mortality risk. Such policies are 
usually signed as “key man” policies within a company (a company insuring 
against the risk of losing important key employees) or to support a mortgage 
loan, which a bank might otherwise be reluctant to grant. (Chaplin, Aspinwall, & 
Venn, 2009, p. 11) 
1.3.5 Whole Life Insurance 
Whole Life Insurance (or Permanent Insurance), unlike Term Life policies, offer 
insurance coverage for the whole lifetime of the insured person. The latter 
usually pays an annual premium which again is being saved in a cash account. 
This premium is held constant over the insured’s lifetime, which usually results 
in an overpayment during younger years to compensate for the increasing 
mortality risk at later years. (New York State Insurance Department, 2011) 
1.4 The Historical Development of the Life Settlements Market 
In the United States, the general concept of selling life insurance policies, and 
hence the foundation for the whole idea of a secondary market for life 
insurances, is based on a Supreme Court case in 1911, when “the policy 
owner’s right to transfer legal ownership and beneficial interest to a third party 
at his or her own discretion” has been confirmed. (Chaplin, Aspinwall, & Venn, 
2009, p. 13) 
A real secondary market for life insurances, however, did not emerge before the 
AIDS crisis in the 1980s. HIV and AIDS victims were confronted with drastically 
shorter life expectations. The first medical forecasts estimated a lifespan of less 
than a year for 50% of the victims and less than three years for 85% of the 
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infected. In addition to the shorter life span, they also needed expensive 
treatment – while at the same time becoming social outcasts, who mostly were 
not able to work anymore. (Lazarus, 2011, p. 254) In life settlement terms this is 
called an impaired life, which will be explained later. For now, it is sufficient to 
know that a life insurance policy on an impaired life is considerably more 
valuable, as the time to maturity (i.e. to receive the death benefit) has 
decreased unexpectedly. As a result of this concurrence – the immediate need 
of AIDS victims for liquidity and the increased value of their life insurance 
policies – a new market was born: the market for viatical settlements also 
known as the viaticals market (Rosenfeld, 2009, p. 7). 
In the market for viatical settlements, desperate AIDS patients sold their life 
insurance policies to unrelated third party investors. The only remaining option 
for policyholders to get rid of their life insurance contracts would have been to 
let the policy lapse and receive a cash surrender value (CSV) from the 
insurance company. This CSV, however, is almost always lower than the actual 
value of the contract, and depending on the contract, it might even be zero in 
some cases. This problem exists because insurance companies have to treat all 
the insured’s of a certain policy equally and therefore may not consider the 
insured’s health status for the calculation of the CSV. As a result, the carrier has 
to assume the loss of a valuable asset (i.e. a client who pays annual premiums 
for several years or even decades) and can only pay the initially agreed upon 
amount which every policyholder would get after a certain amount of time with a 
certain cash balance on the savings account. Hence, as long as an investor 
would pay more than the CSV, the AIDS victim would prefer to sell through the 
viaticals market instead of letting the life insurance policy lapse. (Chaplin, 
Aspinwall, & Venn, 2009, pp. 8-9) 
In the mid 1990s, this market for viatical settlements crashed abruptly. 
Scientists discovered antiretroviral protease inhibitors for HIV/AIDS treatment, 
thus significantly increasing the life expectancy of the diseased policyholders 
(Dunlap, 1996). While this development was most fortunate from an ethical 
point of view, it caused much trouble for the investors. For them, the increased 
life-span translated into far more premium payments than originally calculated, 
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ultimately leading their whole investment into a loss. (Becker & Prihoda, 2010, 
p. 5) 
While the viaticals market did crash, the secondary market for life insurances 
did not. Instead, investors shifted their focus from AIDS victims “to other groups 
of terminally ill policyholders and, ultimately, to elderly insureds” (Lazarus, 2011, 
p. 255). With AIDS victims only constituting for about 20% of the terminal ill 
people during that time, other terminal diseases such as cancer or Alzheimer 
were more common and hence the foundation for a potentially larger market 
(Dunlap, 1996). This market is nowadays known as the market for life 
settlements. 
In 1996 the inception of the U.S. American life settlements market was 
facilitated by the Health Insurance Portability and Accountability Act (HIPAA). 
This act confirmed the policyholders’ right to sell their life insurance policies 
and/or its beneficial rights to a third party. While not explicitly forbidden before, it 
must be mentioned that in the United States life insurances are regulated at 
state level while the HIPAA constitutes national law. The single states still 
define what insurable interest is, but the nationwide permission to sell life 
insurance policies provided the necessary reassurance to investors to develop 
a real market for life settlements. (Becker & Prihoda, 2010, p. 5) 
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2 Transaction Processes and Involved Parties 
2.1 Overview 
The first chapter provided an overview on the very basics of life settlements. 
Now it is time to describe how actual life settlement transactions are done and 
which participants are involved. Chapter 1.2 and Figure 1 already introduced a 
few basic participants, namely the policyholder, a purchaser, and the insurance 
company. In reality, however, life settlement transactions and their participants 
are more complex. 
2.2 Life Settlement Transaction Participants 
(Chaplin, Aspinwall, & Venn, 2009, pp. 15-18) divide the participants in a life 
settlement transaction into direct and indirect participants. 
2.2.1 Direct Participants 
Direct participants, according to (ibid.) “are directly involved with the movement 
of the policy and the transfer of title”. They are as follows: 
• Policyholder: 
The original policyholder who sells his life insurance policy can be a 
natural or an unnatural person. 
• Agent: 
Usually this is the life insurance agent who originally sold the policy to 
the policyholder. The agent’s role is to mediate between policyholder and 
broker. 
• Broker: 
The life settlements broker has to represent the policyholder’s interests 
when dealing with a provider. One way of doing so is to submit the policy 
to as many providers as possible in order to achieve the best market 
price. In states which regulate life settlements, a broker is required. 
• Provider: 
The life settlements broker is the “buyer” of the policy, even though he is 
rather an intermediary between seller and investor. Further roles depend 
on the state’s regulations and may range from retaining records, 
servicing the transaction after completion to the documentation of the 
transfer. Like the broker, a provider is required in regulated states. 
13 Life Settlements – The Secondary Market for Life Insurances 
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(Rosenfeld, 2009, p. 14) regards the providers as the lynch pin of the life 
settlements industry, as they are the point where the worlds of finance 
and insurance flow together. (Seitel C. , 2007) describes providers as 
“portal to institutional investors and a gateway to settlement brokers” who 
play “a pivotal role in the secondary market supply chain”. 
• Investor: 
The investor, also called funder, is the ultimate owner of the life 
insurance policy after the life settlement transaction is finished. The 
investor receives the policy from the provider. Most investors are banks, 
hedge funds or SPVs, but might as well be natural persons. 
• Other direct participants: 
Without going too much into detail, the literature also knows further 
participants which, however, are not important for the general 
understanding and will be described when the need should arise. These 
are the escrow agent, the trustee, and the collateral manager. 
2.2.2 Indirect Participants 
Indirect participants, according to (Chaplin, Aspinwall, & Venn, 2009, p. 15), 
“provide services that are associated with the transaction”. They are as follows: 
• Insured: 
The insured is the natural person whose life the original life insurance 
policy is based on (and still will be after a life settlement deal). The 
insured’s consent is required to close the deal, but – unless he is also the 
policyholder – he is not the direct counter-party. 
• Insurance Company: 
Also referred to as carrier, the insurance company originally issued the 
life insurance policy, receives the premiums, and pays the death benefit 
upon maturity. 
• Medical Underwriter: 
The medical underwriter, usually a company such as 21st Services or 
AVS specialized on medical underwriting, provides a life expectancy 
report for the insured. Based on general mortality tables, the insured’s 
health status and other circumstances, the medical underwriter 
Life Settlements – The Secondary Market for Life Insurances
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calculates the expected life span of the insured, which will be an 
important part of price calculation 
2.3 Life Settlement Transaction Processes
There are several ways to describe the process of a life settlement tra
The most extensive version is by 
and has already been covered in great detail
illustrates a supply chain consisting of twenty
purpose of proving that the whole process of setting up a life settlement is 
immensely tedious and usually takes three to four months to complete.
This paper will take a more illustrative approac
flows across. Inspired by 
shows a very basic flow from one policyholder through his agent to a few 
brokers. These brokers make the polic
review and evaluate the policy and, if interested, buy and resell it to an investor.
Figure 2. Self-provided adaption of (Chaplin et. al, 2009).
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An alternative way of illustrating the life settlement supply chain is displayed in 
Figure 3 (McNealy & Frith, 2006, p. 31). 
 
Figure 3. McNealy & Frith, 2006, p.31. Schematic of the Life Settlement Supply Chain 
Still simplified, this value chain starts with a policyholder consulting their choice 
of advisor (e.g. an agent or attorney) to contact a broker. The rest remains as 
described above. A more complex diagram is provided in Figure 4. 
 
Inspired by (Casey & Sherman, 2007, p. 56), the diagram shows the 
relationship of the major actors. An important added step to the previous two 
illustrations is the inclusion of one or more medical underwriters, whose tasks 
are described in 2.2.2 and 3.5. Medical due diligence is a keyword often found 
in life settlement-related literature, as a lack thereof is an issue often found in 
Life Settlement Provider 
Conducts due diligence, 
negotiates for the purchase of the 
policy, “packages” policy and 
services for benefit of investor 
Policyholder/ Insured Investor 
Life Settlement Broker 
Medical Due Diligence, 
Life Expectancy 
Analysis, Actuarial 
Evaluation, Pricing and 
Negotiation 
Tracking Premium 
Payments and Other 
Post-Sale Activities 
Arranged for by Life 
Settlement Provider 
Investor Advisor 
Solid Lines = Title Transfers 
Dotted Lines = Adisors along the path 
Figure 4. Self-provided adaption of Casey & Sherman (2007, p.56). Life Settlement Transaction 
“Players” 
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real transactions and its consequences can be severe as far as the calculation 
of expected return goes. 
In his article “Lurking Pitfalls: Due Diligence in Life Settlement Transactions”, 
(Freeman, 2007, pp. 83-86) suggests to take care of the following criteria to 
complete thorough due diligence on a life settlement transaction: 
• Verification: 
Every document on the policyholder should be examined for 
inconsistencies, as about 50% of the policies turn out to contain wrong 
information when checked with due diligence. This includes even the 
most basic information such as names or social security numbers. 
• Due Diligence also for Trust Documents: 
Transactions with trust-owned life insurance policies are not uncommon. 
Still, many brokers and providers are rumoured to never check the 
underlying trust documents. For example, trust documents require 
certain formal procedures, such as the signing by an appointed 
“successor trustee”. Other trusts only allow the sale of policies to entities 
with an insurable interest, or the deal has been sealed by a trustee 
lacking the proper authority. 
• Compliance with State Regulations: 
In the United States, life insurance is regulated at state level, essentially 
creating 51 different life settlement markets (cf. 4.4). Therefore, individual 
regulations, e.g. for pricing and disclosure, have to be taken into account 
carefully. 
• Background Checks: 
Basic background checks on the policyholders have to be run, especially 
as a lot of information is publicly available and cheap to come by. No 
judgement should be levied against the policyholder and in the case of 
bankruptcy, the policy should not be involved. 
 
He concludes by pointing out that, even though the life settlements market is 
growing and maturing, insufficient due diligence still remains a weakness of the 
market (p.86). 
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A yet more comprehensive view of the life settlement transaction process is 
being provided by (Perdon, Tomkins, Allsop, & Williams, 2011, p. 4) of 
Arbuthnot Latham Private Bankers. This illustration is displayed in Figure 5. 
 
Figure 5. (Perdon, Tomkins, Allsop, & Williams, 2011, p. 4). Life Settlements Transaction Process 
This diagram actually shows all relevant players and transactions: The 
policyholder selling a life insurance policy either through an agent or directly to 
a broker, the broker acting as an intermediary to the life settlements company 
(i.e. the provider), the provider paying premiums to and receiving the death 
benefit from the insurance company, and a medical underwriter conducting a 
life expectancy report for the life settlements company (although in reality it 
often works for the broker, who then redirects that information to the provider). 
Optionally, the policyholder might directly offer his policy to a life settlements 
company. 
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3 Life Settlements as an Asset Class 
3.1 Overview 
The first two chapters shaped a basic framework on the development, 
terminology and transaction procedures of life settlements. This chapter will 
now explain life settlements as an asset class and show their valuation in a 
more scientific way. 
3.2 The Valuation of the Underlying Life Insurance Policy 
Before the valuation of life settlements can be discussed, the valuation of its 
underlying has to be explained first. In this case the underlying asset is the life 
insurance policy. 
The courses at the chair for Financial Services of the University of Vienna have 
taught several criteria which influence the value of a life insurance policy in 
regard to the value of a life settlement. (Becker & Prihoda, 2010, p. 8) have 
summed up four major factors for determining said value: The policyholder’s life 
expectancy, the expected premium payments, fees imposed by the insurance 
company, and the amount of death benefit paid upon maturity. 
• Life Expectancy of the Policyholder 
Obviously the expected lifespan of the insured is a key metric, as it directly 
determines the expected number of premium payments. Hence, a policy 
based on a potentially longer life is worth more to insurance companies and 
less to potential investors on the secondary market. The projected life 
expectancy is determined by standardized statistical and actuarial methods 
based on mortality tables. While actuaries are in no way fortune tellers, 
according to the law of large numbers, an insurance company with a high 
enough amount of policies will be able to foresee the average mortality risk 
of a certain insured quite accurately, since an increasing number of cases 
means that statistical and actual values should converge. In reality, 
however, investors still fight the problem of inaccurate predictions, which 
(Freeman, 2007, p. 83) sees as “the single most pervasive risk associated 
with a life settlement”. 
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• Expected Premium Payments 
Directly derived from the policyholder’s life expectancy is the expected 
number of premium payments to the carrier. Again, the more premium 
payments to expect, and the higher their monetary amount, the lower is the 
policy’s attractiveness towards investors. 
• Fees 
Fees charged by the insurance company for administration and processing 
have to be considered as well, with a diminishing effect on the policy’s value 
to investors. 
• Death Benefit 
Last but not least, the asset’s value is co-determined by the death benefit, 
the carrier’s payment to the policyholder upon maturity. It is the sole reason 
why investors are interested in buying life insurance policies, so the higher 
amounts directly translate into a higher value. 
 
As a result, the policy’s value to an investor can be summarized as the death 
benefit minus expected premium payments (number x amount) and fees. Figure 
2 shows this calculation graphically. 
 
Figure 6. Self-provided diagram. Value of a Life Insurance Policy 
It should now be even clearer how each factor (premiums, fees, and death 
benefit) influences the policy’s value. 
3.3 The Difference between Normal and Impaired Lives 
Chapter 1.4 already mentioned that investors prefer policies based on short life 
expectancies. In particular this lead to the inception of the market for viatical 
Value Premiums Fees
Death Benefit
Life Settlements – The Secondary Market for Life Insurances 20 
 
 
Magisterarbeit  Alexander Becker, Bakk. 
settlements, betting on the lives of AIDS patients, and the market for life 
settlements, doing the same for the lives of terminal ill and elderly people. 
The business term for these cases is “impaired life”. An impaired life is “a life 
that has, through the acquisition of medical conditions, a lower life expectancy 
compared to that of the population covered by the subject population” 
(Rosenfeld, 2009, p. 6). An important assumption for further discussion is that 
the “acquisition” of such a medical condition has occurred after the policy was 
signed and was not known to either policyholder or insurance company when 
the terms were agreed. Therefore, the illness has not been taken into 
consideration for the calculation of the premium payments and the death 
benefit, resulting in a sooner time to maturity than expected. Figure 3 illustrates 
how a shift from a normal life to an impaired life affects the value of the life 
insurance policy. 
 
Figure 7. Self-provided diagram. Difference between Normal and Impaired Lives 
Since the impairment has not been considered in its original calculation, the 
death benefit (as well as the fees) will remain unchanged. However, fewer 
premium payments have to be paid until maturity. Hence, the difference i.e. the 
value of the policy increases – sometimes drastically. Also, the decreased time 
to maturity increases the net present value of the death benefit (“One Euro 
today is worth more than one Euro tomorrow”). 
Value
Value
Premiums
Premiums
Fees
Fees
Impaired Life
Normal Life
Death benefit
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3.4 The Valuation of a Life Settlement 
Thus far, the valuation of the underlying – i.e. the life insurance policy – has 
been explained. Now the same will be done for the actual asset, the life 
settlement. (Rosenfeld, 2009, p. 23) defines it as “the payment of a fixed sum at 
an undetermined time in the future”. Figure 4 shows the cash flows of a single 
life settlement graphically. 
 
Figure 8. Self-provided diagram. Cash Flows of a Life Settlement 
The investor initially pays a certain purchase price to the original policyholder 
(or in fact to an intermediary, i.e. to a provider). This is followed by an unknown 
number “n” of premium payments to the carrier and, eventually, a death benefit 
which is received once the original policyholder dies. Apparently, these cash 
flows show a certain similarity to those of bonds, as shown in Figure 5 for 
comparison with Figure 4. 
 
Figure 9. Self-provided diagram. Cash Flows of a Bond 
Purchase 
Price
Premium Premium Premium Premium Death Benefit
Am
o
u
n
t
Time
Cash Flows of a Life Settlement
Bond Price Coupon Coupon Coupon Coupon Face ValueA
m
o
u
n
t
Time
Cash Flows of a Coupon Bond
Life Settlements – The Secondary Market for Life Insurances 22 
 
 
Magisterarbeit  Alexander Becker, Bakk. 
And indeed, in the media life settlements are often dubbed as “death bonds” 
(Goldstein, 2007), mostly to express negative sentiments. From a financial point 
of view, life settlements can be described either as bonds or as derivatives, the 
underlying being the life expectancy of the original policyholder (Rosenfeld, 
2009, p. 28). 
Mathematically speaking, life settlements and bonds share initial expenditures 
and a certain pay-off upon maturity. However, instead of receiving regular 
coupon payments (in the case of bonds), an investor holding a life settlement 
has to pay regular premiums. Therefore, a life settlement could be described as 
a “negative-coupon bond” (Becker & Prihoda, 2010, p. 15). The second main 
difference is the time to maturity, which is known for a bond but unknown for a 
life settlement, the latter being based on mortality tables and expectations. This 
is where arguably the biggest risk for investors lies, as estimates have to be as 
exact as possible (Freeman, 2007, p. 83). 
As a result, (Bakos & Parankirinathan, 2006, p. 47) conclude that “the value of a 
life insurance policy at any given time is simply the present value of future death 
benefits less than the present value of the future premiums as of that time”. 
3.5 The Pricing of a Life Settlement 
3.5.1 The Theory behind Life Settlement Pricing 
After clarifying the cash flows a life settlement’s value is composed of, this 
chapter will discuss the actual pricing of the asset. 
Applying the concept of bidding and asking prices, for any trade to occur, a 
price must be found that is greater than the seller’s minimum asking price and 
smaller than the buyer’s maximum bidding price (Pa < P < Pb). In a life 
settlement, the asking price is the minimum price at which the policyholder 
would be indifferent between selling the policy on the market and surrendering it 
to the carrier. Hence, for the policyholder to engage in a life settlement 
transaction, the minimum asking price has to be greater than the CSV. On the 
other hand, the maximum bidding price any investor would be willing to pay 
must be smaller than the death benefit. And since the investor will also have to 
pay the premiums (and fees), the maximum bidding price must be smaller than 
the difference of death benefit and expected premium payments. 
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Thus, the following inequality must hold true for any life settlement transaction 
to take place: 
[Cash Surrender Value] < [Purchase Price] < [Death Benefit 
Otherwise, at least one of the involved parties
transaction. (Becker & Prihoda, 2010, p. 7)
Figure 6 tries to show this concept 
Figure 10. Selv-provided illustration of the concept of asking and bidding prices
While this is the theory 
pricing approaches do exist: the deterministic method, the probabilistic method, 
and stochastic simulation, although the latter is rarely 
rather be regarded as an option for the future 
p. 35). Therefore, the industry currently knows two ways of pricing life 
settlements: Deterministic Pricing
expectancy, and Probabilistic Pricing
probability density function of death conditional on survival until the transaction 
time” (Erkmen, 2011, pp. 72
Pricing is preferable, as it constitutes “
industry according to Milliman USA”
old and outdated approach
However, regardless of the approach which is being used, the abovementi
concept of asking and bidding prices holds true. The price of a life settlement 
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contract to a provider will always be derived from the expected policy benefits 
minus the expected policy costs, using the investor’s expected ROI to calculate 
the gross economic value of the life settlement contract. The difference rather 
lies in the way mortality/life expectancy and interest discounts are being applied 
on the cash flows (Zollars, Grossfeld, & Day, 2003, p. 35). 3.5.3 and 3.5.4 will 
discuss the difference between deterministic and probabilistic pricing. 
3.5.2 The Importance of Medical Underwriting 
Obviously, calculating an accurate projection of the insured’s life expectancy is 
of utmost importance, as the policy costs are directly dependent on it. For both 
methods, deterministic and probabilistic, the mortality rates for the life insurance 
policies are determined by a medical underwriting process. The underwriter 
considers all known risk factors of the insured (such as age, gender and health 
status) and calculates a multiplier called “underwriting multiple”. This 
underwriting multiple is then applied to the standard mortality table in order to 
calculate a particular individual’s life expectancy. 
This process leaves the potential investor with the following decision variables 
(Schwartz & Wood, 2008): 
o Age, gender, and smoking habits (e.g. 76-year-old male, non-smoker) 
o The death benefit i.e. face amount (e.g. $300,000) 
o Annual fees and maintenance expenses (e.g. $500 p.a.) 
o Annual premium payments (e.g. $12,000 p.a.) 
o A life expectancy (e.g. 10 years) based on an underwriting multiple 
(e.g. 150%) 
Obviously there is still a lot of margin for error, especially when it comes to life 
expectancy and mortality rates. However, this approach is not about exactly 
determining an individual’s life-span (which is per se impossible) but about 
calculating an accurate expected value; both, the deterministic and the 
probabilistic approach rely on a well-diversified portfolio of life settlements and 
ultimately on the law of large numbers. 
After determining the life insurance policy’s values as described above, 
mortality and interest discounts are applied to calculate a price for the life 
settlement. This can be done in two ways: deterministic or probabilistic. 
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3.5.3 Deterministic Pricing 
As mentioned in 3.5.1, Deterministic Pricing is an outdated approach (Finsinger, 
2011), which has been the industry’s standard during the era of viatical 
settlements (cf. 1.4) and the early years of life settlements when life 
expectancies were assumed to be shorter and easier to predict (Zollars, 
Grossfeld, & Day, 2003, p. 35). 
This method simply assumes a certain mean life expectancy upon which the 
investor will receive the death benefit. The actual distribution of life expectancy 
is being ignored. Reinsurance arrangements (which usually guarantee a death 
benefit payment 0-2 years after mean life expectancy) can be used to hedge the 
longevity risk, otherwise a longer mean life expectancy might be assumed 
(p.35). 
The price of the life settlement is the discounted value of the death benefit 
minus the discounted value of the premiums and fees which have to be paid. 
The discount rate is the provider’s expected ROI (p.36): 
Price  	
 
1    
Premiums  Fees !
1   "
#
"$%
   
Even though this model is no longer being used on the life settlements market, 
it does come with the advantages of being the simplest, easiest and most 
conservative approach. On the other hand, it heavily relies on the law of large 
numbers. Only if a sufficiently large enough number of homogeneous policies 
with identical mortality risk is held within a portfolio, the investor can assume 
that deaths do averagely occur around mean life expectancy. Since the 
distribution of life expectancy is not taken into consideration, the potential gains 
from early deaths to fund premiums for other ongoing policies in the portfolio 
are ignored. This results in potentially lower expected returns on the total 
portfolio (Ibid.). 
3.5.4 Probabilistic Pricing 
The probabilistic pricing method is the current standard for the life settlement 
industry. Unlike the deterministic method, it does not build on the assumption of 
all deaths within a portfolio occurring about the mean life expectancy. This 
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portfolio is rather considered as “a collection of identical insureds and policies”. 
Another major difference is that the cash flows (death benefit and premium 
payments) are not just simply discounted with the investor’s expected return on 
investment. Instead, mortality-adjusted net cash flows are created first, by 
applying mortality rates to all projected premiums, benefits, and expenses. 
These mortality-adjusted new cash flows are then discounted as seen in the 
deterministic pricing model. Therefore, for every cash flow period (e.g. year) the 
according mortality risk is included individually, leading to the inclusion of the 
distribution of life expectancy into the price calculation. The result is an actuarial 
new present value, which brings the probabilistic method in line with the 
methods used by life insurance carriers (Finsinger, 2011). 
Putting the probabilistic pricing method into formulas would look as follows. To 
calculate the price, the investor’s expected/desired return on investment (e.g. 
9.0%) is applied to discount all mortality-adjusted net cash flows. To calculate 
the latter, for every cash flow period (assuming years) an expected annual 
death benefit is calculated, based on the mortality tables and the underwriting 
multiple. The purchase price is then calculated as a sum of these cash flows: 
Price =  
Rate of Mortality in Year t 0 Total Death Bene5it  Premiums  Fees !1   "
#
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Comparing this pricing formula to its counterpart in 3.5.3, it becomes apparent 
that the main tangible difference for the investor (by incorporating mortality-
adjusted cash flows) is that every cash flow period includes an expected death 
benefit, which can be used to fund premium payments for other policies in the 
portfolio. Hence, the probabilistic method does indeed consider that deaths 
might occur before the mean life expectancy, which will potentially lead to a 
higher economic value than through deterministic calculations. 
However, (Finsinger, 2011) and (Zollars, Grossfeld, & Day, 2003, pp. 36-37) 
observe that the probabilistic method is not void of disadvantages either. As 
with the deterministic method, it relies on the law of large numbers to achieve 
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the expected pattern of deaths. Moreover, its level of modeling complexity is 
higher (increasing the calculation efforts) and by including mortality rates more 
often, inaccurate mortality predictions during the underwriting process would 
have an even heavier impact on this method. 
3.6 No Correlation to Financial Markets as Additional Non-
Monetary Value 
Whether or not the expected utility hypothesis is being employed, life 
settlements certainly do offer additional benefits to investors, which cannot 
directly be measured in monetary values. The major advantage in this regard is 
the fact that life settlements are uncorrelated to other financial assets, since the 
underlying – human mortality – is indeed completely unrelated to the 
movements of the financial markets (Becker & Prihoda, 2010, p. 2). It is 
important to note, however, that this hypothesis can only hold true if the life 
settlements are held until maturity. If sold prematurely or repackaged into other 
financial instruments, they become part of the capital markets just like any other 
common financial asset (cf. 3.9: Investment Strategies). Thus we will now 
assume a “buy and hold” strategy for the rest of this chapter. 
The claim that life settlements are uncorrelated to other financial assets 
because human mortality is not linked to the movements of the financial 
markets does sound reasonable. But (Rosenfeld, 2009, pp. 26-28) actually went 
as far as measuring this assumption empirically. For this purpose he compared 
life settlements with four other established asset classes, using publicly 
accessible indices as indicator. These were: 
o The S&P 500 Index (SPX) for the stock markets 
o The US iShares Aggregate Bond Index (AGG) for the bond markets 
o The US iShares Dow Jones Real Estate Fund Index (IYR) for the real 
estate markets 
o The US iShares S&P GSCI Commodity Indexed Trust (GSG) for 
commodities 
For measuring the performance of life settlements, the Goldman Sachs QxX 
Index was employed, which existed during the observation period (12 months 
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from 2008 to 2009) but actually has been cancelled in December 2009 
(Mercado, 2009). 
(Rosenfeld, 2009) now created a correlation matrix, pitting these five asset 
classes against each other in terms of “returns on indices that correspond to 
various asset classes”. A replica of this matrix is shown in Table 1. 
 Life Settlements Stocks Bonds 
Real 
Estate 
Commodities 
Life Settlements - 0.09 -0.35 -0.16 0.21 
Stocks 0.09 - -0.45 0.39 0.54 
Bonds -0.35 -0.45 - 0.44 -0.09 
Real Estate -0.16 0.39 0.44 - 0.44 
Commodities 0.21 0.54 -0.09 0.44 - 
Table 1. Self-provided replica of Rosenfeld's (2009, p.27) Correlation Matrix 
Clearly, life settlements have proven to be unrelated or even negatively 
correlated to stocks, bonds, and real estate (quod erat demonstrandum). 
Furthermore, (Rosenfeld, 2009) also compared the volatility of these five 
indices. The result of this research is listed in Table 2. 
 
Life 
Settlements 
Stocks Bonds Real Estate Commodities 
Standard 
Deviation 
0.00026 0.05939 0.02439 0.13063 0.12076 
Table 2. Self-provided table based on Rosenfeld (2009, p.26) 
Summarizing the results of both tables, he then concludes that “returns on a 
well-diversified portfolio of longevity-mortality assets, such as the QxX index, 
are uncorrelated with and exhibit significantly lower volatility than returns on 
equities, bonds, real estate, and commodities” (p.28). 
(Stone, 2009, p. 107), among others, agrees that the performance of life 
settlements is not linked to that of the capital markets, the only link being the life 
insurance company’s solvency. (Dorr, 2008, p. 62) points out  that even though 
29 Life Settlements – The Secondary Market for Life Insurances 
 
 
Magisterarbeit  Alexander Becker, Bakk. 
life settlements are non-correlated assets, they still suffer from the market’s 
illiquidity as borrowing money has become more difficult during the financial 
crisis. 
3.7 Taxation Issues 
When it comes to taxation rules for life insurances policies and life settlements, 
the following applies in the United States. 
For cash values received from an insurance carrier, only the excessive amount 
over the premiums and fees paid for the policy is taxable. The death benefit 
itself is completely tax-free. However, if the policy has been “subject of a 
transfer for value” (such as it is in the case of a life settlement transaction), the 
difference between death benefit and costs has to be taxed. Also, premiums 
paid until maturity may not be deducted from taxable income; the same applies 
for interest paid in connection with loans for life insurance policies. (Gelfond, 
2009, p. 84) 
Furthermore, all taxable amounts in conjunction with surrendering life insurance 
policies are subject to income tax (10-35%). However, for life settlement-related 
transactions the lower capital gains tax (5-15%) applies to the difference of 
selling price and the maximum of [CSV, Premiums paid]. For investors, this 
does not make a difference, since capital gains tax has to be paid for the profits 
on all financial instruments. But for policyholders this provides an additional 
reason for selling unwanted policies on the secondary market instead 
surrendering the policy back to the insurance company. (Becker & Prihoda, 
2010, p. 11) 
3.8 Investment Strategies 
(Seitel C. L., A Provider's Reflection from Inside the Life Settlement Industry: 
Understanding the Chaotic Environment, 2009, pp. 70-71) observed three 
distinct investment strategies revolving around life settlement, which are being 
pursued by different players among the world’s largest financial institutions. 
These strategies are “buy and hold”, “leverage”, and “buy, package, and resell”. 
When praising a life settlement’s added value of not being correlated to the 
financial markets (cf. 3.7), it is important to note that this only applies to the “buy 
and hold” strategy. 
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3.8.1 “Buy and Hold” Strategy
The simplest strategy is to acquire a lif
settlements and hold it until maturity, upon which the death benefits are 
received. This is a strategy being followed by investors such as ILSP, HBC, Life 
Bond, Life Partners, and Life Plus
Inside the Life Settlement Industry: Understanding the Chaotic Environment, 
2009, p. 70). Again, whenever someone points out that life settlements are not 
related to other assets on the financial markets or
person, they usually assume a “buy and hold” strategy.
3.8.2 “Leverage” Strategy
Generally, investment leverage means to borrow money in order to invest 
(Sengkee & Roberts, 2011)
although we now look at this strategy from the lender’s perspective.
leverage provider (e.g. Commerce Bank, Dresdner Bank, or the Royal Bank of 
Scotland) lends money to the owner of a life settlement portfo
interest rate being below the portfolio’s projected rate of return. At the same 
time, the lender’s risk is being minimized by having the portfolio of life i
policies as collateral (Seitel C. L., A Prov
Settlement Industry: Understanding the Chaotic Environment, 2009, p. 71)
Figure 7 illustrates this strategy in a simple way.
Figure 11. Self-provided illustration. The Leverage Strategy for Life Settlements
3.8.3 “Buy, Package, and Resell” Strategy
Also referred to as “intermediation strategy”, this strategy involves the purchase 
of various life settlements in order to repackage them into several 
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instruments in order to offer them to their clients. This approach has been 
followed by some major players such as Deutsche Bank, Merrill Lynch, and 
Lehman Brothers. With the effects of the financial crisis by the end of 2008, 
however, most of these major investment banks stopped all of their financing 
projects, including life settlements. (Seitel C. L., A Provider's Reflection from 
Inside the Life Settlement Industry: Understanding the Chaotic Environment, 
2009, p. 71)  
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4 The Risks for Life Settlement
4.1 Overview 
Chapter 3.7 has shown that life settl
volatility and low to negative correlation to other asset classes, which all add to 
the asset’s value. However, in the same way there are also certain risks unique 
to life settlements, which have a decreasing eff
(Perera & Reeves, 2006)
life settlement brokers, which are displayed in Figure 8.
Figure 12. Self-provided adaption of
Life Settlement Brokers 
These risks, which can be categorized 
individual policies, will be discussed in the following subchapters.
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4.2 Contestability Period 
During the contestability period, the carrier has the right to deny the payment of 
the death benefit on the grounds of fraud, material misstatement, concealment, 
and other missing details at the time of the underwriting process. Even though 
contestation does not happen often, insurance companies tend to take a closer 
look at policies which have been traded as life settlements. The contestation 
applies only to the difference between death benefit and premiums paid. So 
even if a claim on the death benefit gets denied, the investor would at least 
receive back the premium payments. (Perera & Reeves, 2006, p. 57) 
A special case of contestability would be suicide contestability, which denies 
payment of death benefits if the insured died through suicide. Therefore when 
buying policies which are still within contestability period, it would be advisable 
to consider suicide statistics for calculations. (Bakos & Parankirinathan, 2006, 
pp. 47-48) 
The contestability period used to last for two years after signing the original life 
insurance policy, but has been extended to five years by the National 
Association of Insurance Commissioners (NAIC) in June 2007. The intention 
was to restrict the policy’s value as a tradable asset during contestability period. 
(Rosenfeld, 2009, pp. 19-20) 
To hedge the contestability risk, investors might seek out a contestability-
insuring company, which covers the contestability risk. Also, it will review the 
underlying underwriting process and confirm or deny the legitimacy of the 
policy. (Perera & Reeves, 2006, p. 57) 
4.3 Missing Body Risk 
If the insured dies without physical proof of their death (i.e. the body is missing), 
insurance companies might delay their payment for up to seven years, or until 
proof of death has been delivered. This would not only decrease the net present 
value of the death benefit, but would also require the investor to keep paying 
annual premiums to the carrier. However, once the time of death has been 
confirmed, overpaid premiums will be reimbursed. Again, for larger portfolios, it 
is possible to insure against this risk. (Perera & Reeves, 2006, p. 57) 
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4.4 Insurable Interest Risk 
The concept of insurable interest is the very essential legal pillar of life 
insurance and arguably remains the most important legal issue for life 
settlement investors today (Chaplin, Aspinwall, & Venn, 2009, p. 24). The basic 
idea is as simple as it sounds: It defines which interests may be insured and 
which ones not. 
In the case of life insurances, insurable interest exists if the policyholder is 
“interested in the continuing health and life of the insured person”, which is by 
default assumed for the policyholder’s own life, the policyholder’s spouses or 
dependants, and in special cases also between a company and its key 
employees (Becker & Prihoda, 2010, pp. 21-22). In addition, economic interests 
by creditors can be considered as insurable interest as well (Perera & Reeves, 
2006, p. 58). The official explanation requires that “(1) there is a close blood or 
legal relationship that engenders love and affection, or (2) there is a reasonable 
expectation of pecuniary advantage through the continued life of the insured 
person and consequent loss by reason of his or her death” (Martin, 2011, pp. 
177-180). The idea behind is that the policyholder must hold a certain “risk of 
loss” to prevent moral hazard in the form of mischief and crimes. Otherwise it 
could be profitable to insure the lives of strangers (without their consent) and 
have them killed in order to receive the death benefit (Rosenfeld, 2009, p. 8). 
The official court statement from 1911 reads as follows: “A Contract of 
insurance upon a life in which the insured has no interest is a pure wager that 
gives the insured a sinister counter interest in having the life come to an end” 
(Martin, 2011, p. 177). 
As opposed to the contestability period of five (formerly two) years, insurable 
interest risk could occur at any time between signing the policy and its maturity. 
The consequences would be drastic, rendering the policy void by law or 
unenforceable against the insurance company. In either case, the investor 
would only receive the premiums already paid thus far. (Perera & Reeves, 
2006, p. 58) 
There is a main difference between US-American and British law in regard to 
insurable interest and life insurance policies. Both require insurable interest to 
close the contract, but the timing is different. British law requires the insurable 
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interest to remain intact throughout the whole lifetime of the insured. U.S. law, 
on the other hand, only requires it to exist at issuance (Chaplin, Aspinwall, & 
Venn, 2009, p. 22). This goes back to the same Supreme Court ruling from 
1911 we have already encountered in chapter 1.4. From there on, life insurance 
policies in the United States were legally recognized as assets, a position later 
confirmed by the HIPAA in 1996 (cf. 1.4). As a result, there is no English life 
settlements market, whereas the secondary U.S. market for life insurances is 
regarded as the most important of its kind. 
Defining insurable interest, however, is what really causes the problems in the 
U.S. market. The reason is that in the USA insurance is regulated at state level, 
the definition of insurable interest being based on the state in which the policy 
has been issued originally. As a result, life settlement investors are rather 
operating on 51 different markets instead of just one market. Another problem is 
that the original policyholder’s motivation for issuing the policy, and hence their 
claim for insurable interest, might be lost over the years and impossible to 
reconstruct. (Chaplin, Aspinwall, & Venn, 2009, p. 24) 
4.5 Incorrect Purchase Price 
4.5.1 Overview 
This section will discuss the risk of paying an incorrect purchase price, more 
specifically the risk of overpaying for a life insurance policy. This is a risk which 
can considerably decrease the return on a life settlement and usually is caused 
by two reasons: Either by mistakes during the underwriting process resulting in 
a wrongly assessed life expectancy, or by using a wrong pricing model (Perera 
& Reeves, 2006, p. 58). As mentioned in 3.6., to deal with these problems, 
(Schwartz & Wood, 2008, pp. 73-75) have come up with five suggestions: 
Stress tests, eligibility criteria, multiple underwriters, pricing criteria, and 
reinsurance. The following subchapters will discuss these methods for reducing 
the risk of paying an incorrect purchase price. 
4.5.2 Stress Tests 
Using stress tests according to (Schwartz & Wood, 2008, pp. 73-74), stress is 
applied to the pricing table using different scenarios in order to address the risk 
of an understated life expectancy, i.e. the risk that the actual life span of the 
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policyholder will be longer than calculated by the underwriting process. The 
original purchase price remains unchanged for this test. The reasons for a 
miscalculation in life expectancy could be the underwriting multiple set too high 
(cf. 3.6) or mortality tables not being conservative enough in their assumptions. 
Obviously, this would directly translate into decreased returns on the 
investment. 
When stressing the level of the pricing table (while keeping the original price), 
one scenario could be to decrease the underwriting multiple (e.g. from 150% to 
120%). Based on this new multiplier, a new (higher) life expectancy and 
therefore a new (lower) projected return on investment would be derived. The 
tangible result of this stress test would be a table which lists the new expected 
returns as a function of additional life expectancy (in either months or years) to 
give an overview over the impact of increased life expectancy on expected 
returns. This table can now be used to determine the percentage of results that 
would be undesired returns, so the investor will now be better able to quantify 
this risk. Tab. 3 shows an example for such a table. 
Additional Life Expectancy Expected Return 
0 months 8.00% 
3 months 7.14% 
6 months 6.30% 
9 months 5.47% 
12 months 4.66% 
Table 3. Schwartz & Wood (2008, p.74). Impact of Increased Life Expectancy on Expected 
Return 
This table clearly shows how deep the impact of too optimistic (or pessimistic, 
from the insured’s point of view) life expectancy values can be on the expected 
returns. As a result, the industry already shifted from the old 2001 VBT to the 
new 2008 VBT mortality tables, which are more conservative as they assume 
longer life expectancies based on new medical and historical data. 
(Seitel C. L., A Provider's Reflection from Inside the Life Settlement Industry: 
Understanding the Chaotic Environment, 2009, p. 71) observed that this simple 
change of mortality tables reduced overall portfolio values by 15-20%. In 
November 2008, the two dominant Life Expectancy Providers 21st services and 
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AVS went even further and increased expected life spans up to 25%. In the 
author’s opinion, this re-adjustment was only partly due to the new mortality 
tables, but rather “an excuse to re-adjust overly aggressive tables”. As a result 
of this adjustment, Life Settlement portfolios dropped in value by as much as 
50%. (Stone, 2009, p. 101) goes even farther as to call it “the most dramatic 
event that impacted the LS market as the financial markets entered the crisis 
stage”, deeming it even more critical than the financial crisis itself. 
4.5.3 Eligibility Criteria 
Investors can use Eligibility Criteria to set quantitative and qualitative 
requirements for acquiring life settlements which are more complex than a 
simple risk-reward calculation. (Schwartz & Wood, 2008, p. 72) list the following 
examples of eligibility requirements for acquiring life settlements or 
pools/portfolios of LS: 
• The insurance company’s ability of paying claims (e.g. by credit rating) 
• Minimum age of the insured 
• Minimum life expectancy 
• Maximum life expectancy 
• Minimum death benefit amount 
• Maximum death benefit amount 
• Minimum number of life settlements to acquire 
• Maximum number of life settlements to acquire 
• Minimum data to be provided by the underwriter as output of the 
underwriting process 
• Minimum number of underwriters until a consensus on life expectancy is 
found (cf. 4.5.4) 
• Diversification requirements (diversify by type of impairment) 
4.5.4 Multiple Underwriters 
As a further way of decreasing the risk of wrong prices caused by inaccurate life 
expectancies, (Schwartz & Wood, 2008, pp. 74-75) propose to hire more than 
one underwriter to calculate the underwriter multiple (“four eyes see better than 
two”). Either the underwriters develop similar multiples, which serves as 
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assurance of their accuracy, or they come to different conclusions which offer 
potential for stress testing. 
Obviously this solution does require a certain investment size to warrant the 
costs of employing additional underwriters. 
4.5.5 Pricing Criteria 
Moreover, (Schwartz & Wood, 2008, p. 75) suggest that “to mitigate risk, at a 
minimum, the investor may demand a higher rate of return or choose a higher 
margin of risk and rely more extensively on the results of the stress tests”. 
4.5.6 Reinsurance 
Life settlement reinsurance companies protect their clients (i.e. life settlement 
investors) from insured people living too long (Bernstein, 2010). As such, they 
further help to mitigate risk, but might also add substantial maintenance costs 
(Schwartz & Wood, 2008, p. 75). 
4.6 Life Insurance Company Credit Risk 
According to (Seitel C. L., A Provider's Reflection from Inside the Life 
Settlement Industry: Understanding the Chaotic Environment, 2009, p. 72) a life 
insurance company’s risk of insolvency is very low, since the life insurance 
industry follows self-regulatory guidelines. In fact, the insurance industry 
supposedly has the “most vigilant financial monitoring and rehabilitation 
procedures in finance today”. Actually, not a single case of an unpaid life 
insurance claim due to a carrier’s insolvency has been recorded in U.S. history. 
Three reasons lead to this extent of safety: 
1. Once an insurance company should be in financial distress, this fact is 
usually recognized early on, since insurance companies have to submit 
annual to quarterly financial reports to their state insurance departments. 
In addition, annual insolvency tests have to be passed for license 
renewal. 
 
2. If this monitoring and early recognition should reveal financial problems, 
the responsible state will appoint a receiver from the insurance 
department to take over the insurance company. This receiver will 
discontinue new business activities and keeps the company running to 
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pay out insurance claims. Usually, most financial troubles can be solved 
with this kind of early intervention, as most financial troubles are caused 
by bad financial management rather than bad quality of held policies. 
 
3. Finally, if the first two steps do not suffice, state guaranty funds act as 
ultimate fail safe. The state guaranty association, which all licensed 
insurance companies are forced to join, would pay all remaining claims 
left after the carrier’s liquidation up to its limit of $300,000 to $500,000. 
Still, some investors might be restricted to certain credit ratings. In this case, 
credit insurance coverage would be a way to hedge the risk of not receiving the 
death benefit due to a carrier’s bankruptcy (Perera & Reeves, 2006, p. 58). 
4.7 Increase in Premiums due to Increase in the Cost of Insurance 
The cost of insurance (COI) reflects the carrier’s mortality risk, which is covered 
by the annual premium payments (Chaplin, Aspinwall, & Venn, 2009, p. 10). 
Generally increasing life expectancies could lead to higher COI and higher 
premium payments, unless the policy is working on a guaranteed basis, which 
means that the premium amounts are fixed and will not be adjusted as the 
carrier’s COI increases. However, this risk is considered to be “negligible or 
non-existent” by most investors (Perera & Reeves, 2006). 
4.8 Longevity Risk 
4.8.1 Overview 
After several individual policy risks, the longevity risk represents a systematic 
risk. (Rosenfeld, 2009, p. 34) defines it as “the risk that the rate of maturity 
within a portfolio will be slower than that predicted by the underwriting and 
actuarial modeling”. 
As a systematic risk it is not a risk associated with single life insurance policies, 
but the risk of a complete life settlement portfolio extending its life expectancy 
(Perera & Reeves, 2006, p. 59). This makes sense as well-diversified life 
settlement portfolios should be assumed by default. Individual longevity risks 
should be diversified away according to the law of large numbers, and only a 
general shift should concern investors. However, if such a general shift should 
occur, the consequences for investors could be severe, as 4.5 has shown the 
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deeply negative impact of added life expectancy on expected returns, up to the 
point where it might have played a major part in the life settlement market’s 
shock in late 2008. In 1.4 we have seen how medical advances have increased 
the life expectancy for the whole population of AIDS victims to bring down the 
market for viatical settlements in the 1990’s. 
And indeed, life expectancy in Europe and North America has increased by 
about one year per decade since the 1960’s due to improving health conditions 
(Chen, Cox, & Yan, 2010, p. 20). In a way it is true that increasing longevity “is 
closer to a certainty than a risk” (Mott, 2007, p. 58). Moreover it is not a problem 
solely linked to the life settlements market, but an issue that is “putting more 
and more pressure on governments, pension funds, life insurance companies 
as well as individuals” (Blake, Brockett, Cox, & MacMinn, 2011, p. 1). (Chen, 
Cox, & Yan, 2010, p. 2) call it a “high-profile risk for pension funds, insurers and 
other companies”. 
As a result, hedging systematic longevity risk is much desired but not that easy 
to achieve. Unsurprisingly, solution proposals are anything but consistent. 
4.8.2 Longevity-Extension Insurance / Mortality Wraps 
(Mott, 2007, p. 58) proposes longevity-extension insurance also known as 
mortality wraps. Issuers of such insurances usually charge a fee of about 30% 
of the pool’s market value. In exchange, the issuer agrees to buy all remaining 
policies on an agreed-upon future date – usually the portfolio’s average life 
expectancy with a few years added as buffer – albeit for a purchase price which 
usually is below the policy’s face value. Furthermore, a lot of these issuers have 
low or no credit ratings. The prices for this kind of coverage are high, since the 
issuers are exposed to adverse selection. Obviously, the life settlement 
investors will only try to insure policies which they believe to outlive the 
projected life expectancy, having a certain advantage when it comes to 
information about the insured’s health. 
4.8.3 Vanilla Longevity/Survivor Swaps 
Survivor swap and longevity swap are two common terms which refer to the 
same thing. (Chen, Cox, & Yan, 2010) argue and demonstrate that longevity 
risk in life settlements could be hedged by using vanilla longevity swaps (VLS). 
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A swap generally is “an agreement by which two parties agree to exchange one 
or more future cash flows, at least one of which is random”, whereas for a 
longevity/survivor swap these random cash flows are dependent on mortality 
(Dowd, Blake, Cairns, & Dawson, 2006, Vol.73, p. 3). In a VLS, those two 
parties exchange a series of payments over an agreed-upon period of time (e.g. 
at t=1, 2, 3, …, T) based on whether or not the life settlement pool’s survival 
rate is higher or lower than expected (p. 4). Payments by one side are fixed, 
whereas the other side’s payments are random amounts based on mortality 
rates (Westland, 2009, p. 17). In swap terminology this is described as “the 
fixed leg linked to the expected survival rate and the floating leg linked to the 
realized survival rate” (Chen, Cox, & Yan, 2010, p. 3). 
This serves as a hedge for a life settlement portfolio’s longevity risk, as the 
following will be achieved: 
• If life expectancy should increase, the LS investor loses money from his 
initial investment, but receives cash flows from the vanilla survivor swap 
• If life expectancy should be lower than expected, the LS investor will gain 
higher returns on his life settlements, but loses money on the survivor 
swap 
• If life expectancy should remain unchanged, returns should be as 
projected 
In either case, with VSS the longevity risk is being hedged for any possible 
scenario.  
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5 The Life Settlements Market
5.1 Overview 
This chapter will cover the life settlements market from two viewing angles. 
First, a general overview over the market will be provided, with an emphasis on 
the more recent developments as 1.4 has already shown
development of the market. The second subchapter will then discuss the ethical 
issues which surround the life settlements market.
5.2 The Modern History
5.2.1 Milestones in Life Settlement History
Figure 9 illustrates an overview of the milestones in life settlement history.
Figure 13. Self-provided illustration of history milestones
As described in 1.4, the market for viaticals started approximately in 1988, at 
the eve of the global AIDS epidemic 
1988
• Inception of the viaticals market
1996
• Crash of the viaticals market
• Inception of the life settlements market
2002
• Life Settlement Association (LISA) founded
2003-2007
• Hype with exponential growth
2008
• Goldman Sachs launching QxX Index
• Beginn of recession/impact of financial crisis
2009
• Shocked market (mortality table adjustments and financial crisis)
• QxX Index taken down
2010
• Market stabilizing
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life settlements market took wings around 1996, when the viaticals market 
crashed due to the discovery of retroviral treatment and the HIPAA confirmed 
the policyholder’s right to sell their policies on the secondary market (Becker & 
Prihoda, 2010, p. 5). 
In 2002, the Life Settlement Association (LISA), self-proclaimed “voice of the 
industry” (Life Settlement Association, 2011) has been founded, including all 
kinds of participating groups (e.g. brokers, providers, and financing entities) with 
the aim of committing to a range of standards (Rosenfeld, 2009, p. 14). 
Coincidently or not, this is when the hype for life settlements started, to last until 
the financial crisis in late 2007 (Seitel C. L., 2009, p. 70). 
At the end of 2007/early 2008, Goldman Sachs launched the QxX Index, a 
monthly index suitable for trading life settlements based on a pool of more than 
46,000 lives. The according database was provided by one of the two leading 
medical underwriters AVS (Blake, Brockett, Cox, & MacMinn, 2011, p. 2). 
However, at the end of 2009/early 2010 this index was taken down again, partly 
because of “the reputational issues associated with life settlements” (Blake, 
Brockett, Cox, & MacMinn, 2011, p. 5) but mainly because “it didn’t sell” (Becker 
& Prihoda, 2010, p. 14). 
In 2007, the life settlements market reached its climax as far as performance 
and volume were concerned, attracting global players such as Goldman Sachs, 
Bear Stearns, Credit Suisse, Merrill Lynch, AIG (Seitel C. L., 2009, p. 70). This 
high point was followed by the emerging financial crisis in the summer of 2007 
and the follow-up recession which began in December 2007 (Stone, 2009, p. 
101). As a result of this crisis, Conning & Co observed that the life settlement 
market was “hit hard” in 2008. This was caused not only by the financial crisis 
and its frozen credit markets, but also by the mortality table revision of two 
major medical underwriters (21st  Services and AVS, cf. 4.5.2) and a 
strengthening U.S. Dollar which decreased returns and demand for non-U.S. 
investors (McGee, 2009). 
Continuing this trend, the life settlement market bottomed out in 2009, 
according to Conning & Co with a 36% decrease in volume compared to 2008 
mainly due to further decreased investor capital (Doss, 2010) and the 
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aforementioned adjustments to mortality tables (Watson, 2010). Also, this 
turned the supply and demand situation of the market upside down, since a 
decrease in demand and the resulting increase in supply gave the advantage to 
buyers in terms of price determination (Conning, 2009a), leading to a “buyer’s 
market” (Conning, 2009b). 
No exact numbers by Conning & Co are freely available for 2010, yet, but 
(Conning, 2010a) announced that the 2010 market has stabilized, with investors 
mainly focusing on Universal Life policies and capital slowly returning to the 
financial markets. (Siegert, 2010, p. 2) also suggests that the 2010 market 
volume operates roughly at the 2009 level. 
Conning & Co has not yet released any reports for 2011, but past publishing 
dates indicate that a October/November release should be expected. 
5.2.2 The Life Settlement Market Volumes from 1989 to 2010 
Based on values mentioned in various sources, Figure 10 displays the total 
market volume for life settlements as a graph. 
 
Figure 14. Self-provided illustration of market life settlement market volumes from 1989 to 2010 
dervied from various sources 
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Following the events listed in 5.2.1, the viaticals market started out with a 
meager $5 million volume in 1989 (Martin, 2011, p. 186), skyrocketed tenfold to 
$50 million in 1990 (Doherty & Singer, 2002, p. 3), and grew into a $200 million 
life settlements market by 1998 (Martin, 2011, p. 186). However, the graph 
shows that this was still only a fraction of the growth to follow. 
Afterwards, during the life settlements hype, the total market volume has risen, 
starting at $2 billion in 2002 (Deloitte Consulting LLP and The University of 
Connecticut, 2005, p. 3) and growing exponentially to $5 billion in 2004, $10 
billion in 2005, and more than $12 billion in 2006 and 2007 (Seitel C. L., 2008, 
p. 55), with 2007 still showing growth “at a frenzied pace” (Ziser, 2008, p. 54). 
This was followed by the slight $11.8 billion decrease in 2008 (Stone, 2009, p. 
101) and anti-climaxed with a 36% decrease to $8 billion in 2009 (McGee, 
2009). A level which supposedly was held in 2010 (Siegert, 2010, p. 2). 
5.3 Ethical Issues Surrounding Life Settlements 
The fact that Life Settlements are financial instruments based on unrelated 
human lives obviously opens the doors for a plethora of discussions on the 
moral and ethical issues of the whole secondary market for life insurances. 
Negative headlines like the Bloomberg Businessweek article “Death Bonds – 
The most macabre investment scheme ever” (Goldstein, 2007) further 
weakened this asset classes’ ill reputation, whose nature is often described as 
“ghoulish” (Martin, 2011, p. 186). This chapter will describe the pros and cons of 
the life settlements market from different viewing angles. 
5.3.1 Arguments Pro Life Settlements 
Despite the bad publicity, the existence of a secondary market for life 
insurances does offer advantages to policyholders. It breaks the monopsony 
power of the insurance companies, who otherwise would be the only ones to 
buy back policies, hence enabling them to dictate the prices i.e. cash surrender 
values as they see fit (Becker & Prihoda, 2010, p. 5). As (Nurnberg & Lackey, 
2010, p. 516) point out, “the secondary market for life insurance policies gives 
the policyholder the economic freedom to choose between a number of buyers 
and, in doing so, to receive a higher fair market price for his or her policy rather 
than just the CSV”, which is always lower than the actual market value for 
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reasons already stated in 1.4. The motivations for policyholders to lapse their 
policies are plentiful. (Doherty & Singer, 2002, pp. 24-25) list the following 
reasons for surrendering a life insurance contract: 
• The policyholder may no longer be able to afford the premium payments 
• The original beneficiary no longer needs the financial protection the 
original policy was intended for 
• A “key man” insurance for a valuable employee might no longer be 
needed, because either the key man left the company or the company 
has gone bankrupt 
• The policyholder might want to surrender just one of many life insurance 
policies 
• The policyholder wants to replace the current individual policy with 
another type of policy 
• The policyholder might need immediate liquidity to pay for medical 
treatment (as seen in the viaticals market) 
• The policyholder might want to live out the rest of his life with a certain 
standard of living 
• The policyholder wants to remove the policy from a trust or estate 
(Rosenfeld, 2009, p. 11) found additional reasons why a policyholder might 
desire to get rid of their policy: 
• The policyholder might have administrative reasons such as estate 
simplification, charity donations, or tax purposes (e.g. to place liquidized 
money into a charitable remainder trust) 
• There might be an arbitrage opportunity between selling the current 
policy and buying a new one with the same cover for less 
The main advantage of getting a higher price at the secondary market is 
especially true for policyholders with impaired life, as their policies become 
considerably more valuable, while the CSV still does not adjust for, and the 
difference between market value and CSV becomes even larger. 
Moreover, (Nurnberg & Lackey, 2010, p. 521), (Doherty & Singer, 2002, p. 24) 
argue that the existence of a secondary market for life insurances increases 
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consumer welfare, and that it even “creates the opportunity for institutional 
investors to push the efficient frontier and construct better portfolios with lower 
risk and higher returns” when applying modern portfolio theory (Dorr, 2008). 
While the same calculations also admit that insurance companies had to 
increase their premiums if life settlements were to become common (because 
insurance companies actually assume that a certain percentage of their clients 
lapses their policies prematurely when calculating the lower premiums), 
(Nurnberg & Lackey, 2010, p. 521) claim that “the increased cost of life 
insurance will not be offset by the increased value of the policies purchased by 
most of the insureds”. 
5.3.2 Arguments Contra Life Settlements 
Populist shouts about the morbidity of life settlements aside, there are indeed 
more substantial negative sides to life settlements from an ethical point of view. 
For once, it cannot be assumed that all policyholders selling their policies act 
rationally. Similar to the irrational choice of using credit cards – where instant 
gratification is traded for future penalties – the option of selling a life insurance 
might lure some policyholders into irrational decisions. After all the policy 
remains “just a piece of paper” for many years, whereas the life settlement 
purchase price would grand the seller instant cash and gratification. (Nurnberg 
& Lackey, 2010, p. 523) 
Furthermore, terminal ill patients – such as the AIDS victims during the viaticals 
era – sell their policies out of desperation, probably because they need the 
money for medical treatment. It can be argued whether such transactions are 
really voluntarily. Moreso since investors usually do not inform the policyholders 
about their range of financial alternatives; many carriers nowadays pay nearly 
the full death benefit for terminally ill policyholders and even if not, many 
policyholders would be better off by keeping the policy and borrowing from a 
bank against the insurance policy. (ibid.) 
Even if in a life settlement transaction “there are no obvious victims, no obvious 
rights violations” (Nurnberg & Lackey, 2010, pp. 524-525), there are other, less 
tangible ethical issues to consider. Life settlements – especially if sold 
irrationally for instant gratification or due to a lack of information – do counter 
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the actual purpose of life insurance, namely to protect family and spouses from 
economic mischief. Also, the fact that after settling a life insurance the 
policyholder’s life is worth more dead than alive to a complete stranger, cannot 
be to his advantage. Lastly, someone who once sold a life insurance policy 
might not be able to get another one ever again, as the insurable interest (which 
does not include the interest to sell the policy on a secondary market) can now 
be questioned by carriers. (Martin, 2011, pp. 197-198) 
(Blake, Brockett, Cox, & MacMinn, 2011) observe that the ethical issues of life 
settlements do not differ from those of the macro-longevity market (e.g. pension 
plans and annuity books), but that the latter is much more capable of “promoting 
good basic research on the analysis of the stochastic mortality forecasting 
models it uses and putting these models into the public domain and has also 
been much more transparent with the data it uses”.  
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6 Conclusion 
This paper discusses the secondary market for life insurances, known as life 
settlements from different angles. 
The first chapter introduces the core concepts and underlying principles of life 
settlements, basically defining it as the purchase of a life insurance policy from 
the policyholder. In exchange for doing so, the purchaser becomes the new 
beneficiary but also pays the premiums until maturity. Several insurance types 
are being explained as well, with Universal Life being the most commonly 
traded life insurance type on the secondary market. Finally, an overview of the 
historical development of the life settlements market is being provided; starting 
from the first related Supreme Court ruling in 1911, which legitimized the 
transfer of policy ownership, to the viatical settlements market set off by the 
AIDS crisis in the 1980’s and 1990’s, until the invention of retro-viral treatment 
and the HIPAA resulting in the inception of the life settlements market as it is 
known today. 
The second chapter explains the basic transaction processes and their parties 
involved. Several direct and indirect participants such as policyholders, agents, 
brokers, providers, investors, insureds, insurance companies or medical 
underwriters get introduced, and their roles within the life settlement transaction 
process are put into perspective. A process which, simplified, uses brokers and 
providers as mediators between policy sellers and investors. 
The third chapter finally discusses life settlements as an asset class. First off, 
the financial valuation of the underlying, i.e. the life insurance policy, is 
determined by these major factors: the policyholder’s life expectancy, the 
expected number and amount of premium payments and fees until maturity, 
and the death benefit which is received upon maturity. Ultimately, the life 
insurance policy’s worth for an investor can be illustrated as the difference 
between expected death benefit and expected premium payments and fees, 
making the policies based on so-called “impaired lives” more attractive on the 
life settlements market. Valuing the life settlement can be compared to a 
“negative-coupon bond”, as the investor pays not only the buying price but also 
regular “coupons” (i.e. the premiums and fees) until finally receiving the face 
value. 
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The pricing of a life settlement is heavily dependent on accurate life expectancy 
predictions during the medical underwriting process, while two methods for 
price calculation do exist. Deterministic pricing simply assumes a mean life 
expectancy at which all policies in the portfolio should mature. Probabilistic 
pricing, on the other hand, considers the fact that some policies might mature 
before reaching mean life expectancy, generating positive cash flows sooner 
than expected, which can be used to fund premiums and fees of other policies 
in the portfolio. 
Furthermore, the chapter takes a look at the life settlement market’s 
uncorrelated nature when compared to other asset classes, taxation issues, and 
the three possible investment strategies: “Buy and Hold”, “Buy, Package, and 
Resell”, and “Leverage”. 
The fourth chapter provides an overview of the potential risks for life settlement 
investors of which there are plenty. An insured might die during the 
contestability period, enabling the carrier to deny the payment of the death 
benefit – the same would apply for a case of suicide contestability. If no body of 
the insured is found, payments could be delayed significantly, while inaccurate 
underwriting processes can have a huge negative impact on expected returns. 
The most significant risk for the US market is, however, the insurable interest 
risk, considering that in the United States, insurable interest is defined and 
regulated at state level, effectively creating 51 different markets. 
The fifth and final chapter mainly recaps the modern history of the life 
settlements market. Most notably the market experienced exponential growth 
from 2003 to 2007 and came to a sudden halt in 2009. However, unlike 
commonly suspected, this was not only caused by the global financial crisis, but 
even more by revision of mortality tables, which delivered significantly increased 
life expectancies, thus decreasing expected returns heavily. Furthermore, life 
settlements have to fight off ethical issues and negative publicity, which mainly 
stems from their rather morbid nature, earning the asset class unpleasant 
names such as “death bonds”. 
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Appendix 
A Verpflichtende deutsche Zusammenfassung der Arbeit gemäß 
Vorschrift 
Die vorliegende Magisterarbeit behandelt das Thema „Life Settlements“, wobei 
es sich hierbei um den Sekundärmarkt für Lebensversicherungen handelt. Es 
wird – soweit nicht explizit anderweitiges erwähnt wurde – lediglich auf den 
U.S.-amerikanischen Markt und dessen Gegebenheiten eingegangen. 
Zunächst einmal wird grundlegendes Wissen über Life Settlements vermittelt. 
Hierzu werden sowohl die involvierten Teilnehmergruppen als auch in 
vereinfachter Form der Transaktionsprozess beschrieben. Abgerundet wird 
dieser Überblick mit einer Liste der gehandelten Versicherungsarten sowie mit 
einem historischen Überblick zur Entwicklung des Marktes. 
Das zweite Kapitel beschreibt anschließend den Life Settlement-Prozess, die 
Wertschöpfungskette und die Marktteilnehmer auf eine detailliertere Art und 
Weise, wobei besonderes Augenmerk auf eine anschauliche und übersichtliche 
Darstellung unter Zuhilfenahme von Diagrammen gelegt wird. 
Kapitel 3 widmet sich nach den theoretischen ersten beiden Kapiteln der 
finanzmathematischen Seite. Hierbei werden Life Settlements nun als 
Finanzanlage betrachtet und dargestellt. Dies umfasst sowohl eine Analyse der 
Wertbestimmung von Lebensversicherungen und Life Settlements als auch ein 
Unterkapitel zur Preissetzung bei Life Settlements. In weiterer Folge wird 
zudem noch auf die Unkorreliertheit dieser Anlagenklasse mit den 
Finanzmärkten und mögliche Anlagestrategien eingegangen. 
Kapitel 4 diskutiert die zahlreichen Risiken für Käufer von Life Settlements. 
Sofern möglich, werden auch Lösungsansätze zu deren Bewältigung geliefert. 
Zu guter Letzt wird in Kapitel 5 auf die Entwicklung des Life Settlement-Marktes 
eingegangen, insbesondere auf die Entwicklung der letzten Jahre. Hierbei wird 
auch ein Erklärungsansatz gesucht, um die Stagnation einer Anlagenklasse zu 
erklären, die zwischen 2002 und 2007 exponentielles Wachstum verbuchen 
konnten. Außerdem wird auf die ethischen und moralischen Fragen 
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eingegangen, welche dem Thema Life Settlements (vor allem in den Medien auf 
negative Art und Weise) anheften.  
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